0001181431-11-026542.txt : 20110503 0001181431-11-026542.hdr.sgml : 20110503 20110503130847 ACCESSION NUMBER: 0001181431-11-026542 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110430 FILED AS OF DATE: 20110503 DATE AS OF CHANGE: 20110503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROWLEY Richard CENTRAL INDEX KEY: 0001352961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 11804116 MAIL ADDRESS: STREET 1: IMCLONE SYSTEMS INCORPORATED STREET 2: 180 VARICK STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd310120.xml CROWLEY FORM 4 X0303 4 2011-04-30 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001352961 CROWLEY Richard SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER BLVD. EAST BRUNSWICK NJ 08816 0 1 0 0 EVP Biopharmaceutical Operatio Common Stock, $.01 par value per share 2011-04-30 4 A 0 100000 11.62 D 100000 D Option to Purchase Common Stock, $.01 par value 11.62 2011-04-30 4 A 0 50000 11.62 D 2012-04-30 2021-04-30 Common Stock, $.01 par value per share 50000 50000 D The right to receive these shares is pursuant to a restricted stock grant that vests as follows: 25,000 on April 30, 2012, and 6,250 shares at the end of each successive three-month period until April 30, 2015, provided that the grantee remains employed by the Company on these dates. These options will become exercisable as follows: 12,500 on April 30, 2012, and 3,125 shares at the end of each successive three-month period until April 30, 2015, provided the optionee remains employed by the Company on these dates. /s/ Irina Azer Ishak for Richard Crowley 2011-05-03